D
PharmaCyte Biotech, Inc. PMCB
$1.04 $0.032.97% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

07/31/2025 04/30/2025 01/31/2025 10/31/2024 07/31/2024
Total Cash And Short-Term Investments 13.44M 15.54M 16.76M 20.84M 32.64M
Total Receivables 4.61M 3.70M -- -- --
Inventory -- -- -- -- --
Prepaid Expenses 238.20K 223.80K 207.40K 493.20K 240.20K
Finance Division Loans and Leases Current -- -- -- -- --
Total Finance Division Other Current Assets -- -- -- -- --
Other Current Assets 820.00K 2.92M -- -- --
Total Current Assets 19.11M 22.38M 16.96M 21.33M 32.88M

Total Current Assets 19.11M 22.38M 16.96M 21.33M 32.88M
Net Property, Plant & Equipment -- -- -- -- --
Long-term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Total Other Intangibles 1.55M 1.55M 1.55M 1.55M 1.55M
Finance Div Loans & Leases LT -- -- -- -- --
Total Finance Div Other LT Assets -- -- -- -- --
Total Other Assets 4.82M 8.77M 6.69M 7.36M 6.65M
Total Assets 45.11M 55.17M 43.83M 55.10M 70.19M

Total Accounts Payable 465.20K 399.20K 484.90K 348.60K 554.00K
Total Accrued Expenses 345.70K 521.10K 709.40K 707.20K 684.10K
Short-term Debt -- -- -- -- --
Current Portion of Long-Term Debt/Capital Leases -- -- -- -- --
Finance Division Debt Current -- -- -- -- --
Total Finance Division Other Current Liabilities 250.00K 1.99M -- 3.72M 6.23M
Total Other Current Liabilities 250.00K 1.99M -- 3.72M 6.23M
Total Current Liabilities 1.06M 2.91M 1.19M 4.78M 7.47M

Total Current Liabilities 1.06M 2.91M 1.19M 4.78M 7.47M
Long-Term Debt -- -- -- -- --
Short-term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Finance Division Debt Non Current -- -- -- -- --
Total Finance Division Other Non Current Liabilities -- -- -- -- --
Total Other Liabilities 458.00K 363.00K 2.38M 6.87M 9.68M
Total Liabilities 1.52M 3.28M 3.58M 11.65M 17.15M

Common Stock & APIC 181.55M 181.49M 181.43M 181.36M 182.73M
Retained Earnings -93.33M -84.97M -96.72M -93.67M -92.20M
Treasury Stock & Other -44.63M -44.63M -44.46M -44.23M -42.81M
Total Common Equity 43.59M 51.89M 40.25M 43.45M 47.71M

Preferred Stock Redeemable -- -- -- -- --
Preferred Stock Non Redeemable -- -- -- -- --
Preferred Stock Convertible -- -- -- -- 5.33M
Preferred Stock, Others -- -- -- -- --
Total Preferred Equity -- -- -- -- 5.33M

Total Common Equity 43.59M 51.89M 40.25M 43.45M 47.71M
Total Preferred Equity -- -- -- -- 5.33M
Total Minority Interest -- -- -- -- --
Total Equity 43.59M 51.89M 40.25M 43.45M 53.04M